Allarity Therapeutics To Present a Dovitinib-DRP e-Poster at the European Association for Cancer Research (EACR) 2021 Virtual Congress - Seite 3

###

Investor Contact:
        Jens Knudsen, CFO        
        [phone]
        Email inquiries: [e-mail]

Media Contact:
        Thomas Pedersen
        Carrotize PR & Communications
        [phone]
        Email inquiries: [e-mail]

Certified Adviser:
Svensk Kapitalmarknadsgranskning AB, Email: [e-mail]. Tel: [phone]

This information is information that Allarity A/S is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication on 29 April 2021.

 

Attachment

• AT Press Release - EACR e-poster June 2021